Logo-jcvtr

J Cardiovasc Thorac Res. 2020;12(3): 222-226. doi: 10.34172/jcvtr.2020.38
PMID: 33123329        PMCID: PMC7581840

Short Communication

Early results of the Resilia Inspiris aortic valve in the old age patients - a retrospective comparison with the Carpentier Edwards Magna Ease

Magjun Shala 1 ORCID, Lars Niclauss 1,2 * ORCID

Cited by CrossRef: 6

1- Ueyama H, Xie J, Hanzel G, Byku I, Paone G, Grubb K, Devireddy C, Greenbaum A, Babaliaros V, Gleason P. Hemodynamic Comparison of Resilia and Sapien 3/Ultra Transcatheter Heart Valves in Transcatheter Aortic Valve Replacement. Circ: Cardiovascular Interventions. 2024;17(1) [Crossref]
2- Torky M, Lamberigts M, Verbrugghe P, Rega F, Meuris B. Propensity Matched Comparison Between Inspiris Resilia and Mechanical Valves in Aortic Position in a Young Patient Cohort. Journal of the Heart Valve Society. 2025;2(1) [Crossref]
3- D’Onofrio A, Cibin G, Tessari C, Lorenzoni G, Luzi G, Manzan E, Gregori D, Gerosa G. Multicenter, propensity-weighted comparison of stented, rapid-deployment and new-generation aortic valves. IJC Heart & Vasculature. 2024;54:101487 [Crossref]
4- Panagides V, Alperi A, Mesnier J, Philippon F, Bernier M, Rodes-Cabau J. Heart failure following transcatheter aortic valve replacement. Expert Review of Cardiovascular Therapy. 2021;19(8):695 [Crossref]
5- Ortoleva J, Gonzalez-Ciccarelli L, Kawabori M, Cobey F, Resor C, Shapeton A. Prosthesis-Patient Mismatch after Transcatheter Aortic Valve Replacement: A New Technology With an Old Problem. Journal of Cardiothoracic and Vascular Anesthesia. 2021;35(8):2253 [Crossref]
6- Condello I. Long-term durability and resilient tissue: ‘the future end of valve in valve!’. 2022;61(6):1450 [Crossref]
7- Avvedimento M, Giuliani C, Zanuttini A, Mengi S, Mas-Peiro S, Poulin A, Beaupré F, Paradis J, Porterie J, Kalavrouziotis D, Dumont E, Mohammadi S, Côté M, Pibarot P, Rodés-Cabau J. Hemodynamic Performance of the SAPIEN 3 Ultra Resilia Valve: Insights From a Propensity-Matched Analysis. Journal of the American Society of Echocardiography. 2025;38(2):132 [Crossref]
8- Sef D, Thet M, Klokocovnik T, Luthra S. Early and mid-term outcomes after aortic valve replacement using a novel tissue bioprosthesis: a systematic review. 2024;65(2) [Crossref]
9- El‐Sayed Ahmad A, Giammarino S, Salamate S, Fehske W, Sirat S, Amer M, Bramlage P, Bakhtiary F, Doss M. Clinical performance of a novel bioprosthetic surgical aortic valve in a German high‐volume center. Journal of Cardiac Surgery. 2022;37(12):4833 [Crossref]
10- Yamamoto M, Yashima F, Shirai S, Tada N, Naganuma T, Yamawaki M, Yamanaka F, Mizutani K, Noguchi M, Ueno H, Takagi K, Ohno Y, Izumo M, Nishina H, Suzuyama H, Yamasaki K, Nishioka K, Hachinohe D, Fuku Y, Otsuka T, Asami M, Watanabe Y, Hayashida K, OCEAN-TAVI investigators O. Performance and outcomes of the SAPIEN 3 Ultra RESILIA transcatheter heart valve in the OCEAN-TAVI registry. 2024;20(9):579 [Crossref]
11- Bernard J, Georges G, Hecht S, Pibarot P, Clavel M, Babaki S, Kalavrouziotis D, Mohammadi S. Mid-term clinical and echocardiographic results of the INSPIRIS RESILIA aortic valve: a retrospective comparison to the Magna Ease. 2023;37(1) [Crossref]
12- Malcolm R, Buckley C, Shore J, Stainthorpe A, Marti B, White A, Deckert J, Vernia M, Carapinha J, López-Marco A, Nikolaidis N, Wendler O. An exploratory cost-effectiveness analysis of a novel tissue valve compared with mechanical valves for surgical aortic valve replacement in subgroups of people aged 55–64 and 65+ with aortic stenosis in the UK. Expert Review of Pharmacoeconomics & Outcomes Research. 2023;23(9):1087 [Crossref]
13- Ahmed A, Aziz T, AlAsaad M, Majthoob M, Altahmody K. Early and late clinical outcomes and cost-effectiveness of aortic valve replacement using the Inspiris Resilia bioprosthesis. J Cardiothorac Surg. 2025;20(1) [Crossref]